Ionis Pharmaceuticals, Inc. (FRA:ISI)

Ionis Pharmaceuticals Revenue

Ionis Pharmaceuticals had revenue of $156.72M USD in the quarter ending September 30, 2025, with 17.12% growth. This brings the company's revenue in the last twelve months to $966.96M, up 20.41% year-over-year. In the year 2024, Ionis Pharmaceuticals had annual revenue of $705.14M, down -10.48%.

• Revenue (ttm): $966.96M
• Revenue Growth: +20.41%
• P/S Ratio: 13.86
• Revenue / Employee: $904.54K
• Employees: 1,069
• Market Cap: 11.42B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	705.14M	-82.51M	-10.48%
Dec 31, 2023	787.65M	200.28M	34.10%
Dec 31, 2022	587.37M	-223.09M	-27.53%
Dec 31, 2021	810.46M	81.19M	11.13%
Dec 31, 2020	729.26M	-393.34M	-35.04%
Dec 31, 2019	1.12B	522.93M	87.20%
Dec 31, 2018	599.67M	85.50M	16.63%
Dec 31, 2017	514.18M	141.40M	37.93%
Dec 31, 2016	372.78M	89.07M	31.40%
Dec 31, 2015	283.70M	69.54M	32.47%
Dec 31, 2014	214.16M	66.88M	45.41%
Dec 31, 2013	147.29M	45.24M	44.33%
Dec 31, 2012	102.05M	2.96M	2.99%
Dec 31, 2011	99.09M	-9.39M	-8.65%
Dec 31, 2010	108.47M	-13.13M	-10.80%
Dec 31, 2009	121.60M	14.41M	13.44%
Dec 31, 2008	107.19M	48.85M	83.72%
Dec 31, 2007	58.34M	43.49M	292.65%
Dec 31, 2006	14.86M	-13.48M	-47.57%
Dec 31, 2005	28.34M	-	-